Chandran Nadarajan/LinkedIn
Jun 7, 2026, 06:57
Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
Chandran Nadarajan, Clinical and Interventional Radiologist at Gleneagles Hospital Kota Kinabalu, shared a post on LinkedIn:
“Catheter-Directed Thrombolysis (CDT)
A minimally invasive, image-guided treatment designed to dissolve dangerous blood clots and restore healthy blood flow.
CDT delivers clot-busting medication directly into the clot, helping to:
- Restore circulation quickly
- Preserve limbs and healthy tissue
- Reduce complications
- Minimize damage to surrounding blood vessels
- Shorten hospital stay and recovery time
This treatment may be suitable for conditions such as:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Acute Limb Ischemia
- Thrombosed Dialysis Access
- May-Thurner Syndrome.”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 15:40Marc Carrier: New ISTH 2026 Data May Simplify DVT Evaluation During Pregnancy
-
Jul 18, 2026, 15:38Hermine Sayiyan: Dreams Do Come True – Often When We Least Expect Them
-
Jul 18, 2026, 15:31Alyaa Al-Mughairy: Presenting Real-World Emicizumab Data at the ISTH 2026 Middle East Summit
-
Jul 18, 2026, 15:25Rim Diab: Presenting Protein S Research as a Rebalancing Strategy at ISTH 2026
-
Jul 18, 2026, 15:22Owen McCarty: Honored to Speak at the 1st Mediterranean Platelet Symposium
-
Jul 18, 2026, 15:18Strengthening Regional Learning for Hemophilia and Sickle Cell Disease Care – Novo Nordisk
-
Jul 18, 2026, 14:54Fabien Mselati: Reflecting on 25 Years of Hemophilia Progress
-
Jul 18, 2026, 14:50Nikola Pantic: Grateful for the People Who Made ISTH 2026 Special
-
Jul 18, 2026, 14:30Denise Rezende: Werfen Reflects on a Successful ISTH 2026 Congress